GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brii Biosciences Ltd (FRA:7SS) » Definitions » Current Accrued Expense

Brii Biosciences (FRA:7SS) Current Accrued Expense : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brii Biosciences Current Accrued Expense?

Brii Biosciences's Current Accrued Expense for the quarter that ended in Dec. 2024 was €0.00 Mil.

Brii Biosciences Current Accrued Expense Historical Data

The historical data trend for Brii Biosciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brii Biosciences Current Accrued Expense Chart

Brii Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
Get a 7-Day Free Trial - - - - -

Brii Biosciences Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Brii Biosciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Brii Biosciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Brii Biosciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Brii Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brii Biosciences Ltd (FRA:7SS) » Definitions » Current Accrued Expense
Comparable Companies
HKSE:06622 HKSE:02511 HKSE:01875 HKSE:06998 HKSE:03681 HKSE:01244 HKSE:02566 HKSE:02898 HKSE:02563 HKSE:02496 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BRIBF:USA 02137:Hong Kong
Address
No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192
Website
https://www.briibio.com
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and worldwide. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.

Brii Biosciences Headlines

No Headlines